CRISPR Therapeutics AG

2026. g. 19. sept. 00:02 UTC

CRISPR Therapeutics AG is advancing in after-market trading, likely in sympathy with Editas Medicine Inc, amid broader economic concerns.

2026. g. 18. sept. 23:01 UTC

CRISPR Therapeutics AG is advancing in after-market trading, moving higher alongside the broader market, following a peak return earlier in the session.

2026. g. 17. sept. 23:51 UTC

CRISPR Therapeutics AG declined modestly during after-market hours on Thursday, breaking a recent trend of higher daily closes.

2026. g. 16. sept. 23:16 UTC

CRISPR Therapeutics AG is declining in after-market hours, trading near the lower end of its one-month range and below its 20-day moving average.

2026. g. 15. sept. 23:01 UTC

CRISPR Therapeutics AG shares are higher in after-market hours, reflecting overall market momentum despite a decline in the New York Empire State Manufacturing Index.

2026. g. 14. sept. 23:01 UTC

CRISPR Therapeutics AG shares are higher in after-market trading, reflecting a strong performance despite declining major indices and rising crude oil prices.

2026. g. 11. sept. 23:01 UTC

CRISPR Therapeutics AG shares are higher in after-market trading, influenced by a narrower-than-expected U.S. budget deficit of $167 billion for August.

2026. g. 10. sept. 20:07 UTC

CRISPR Therapeutics AG shares are lower amid a broader market decline following the European Central Bank's interest rate hike and rising Treasury yields.

2026. g. 8. sept. 20:07 UTC

CRISPR Therapeutics AG shares are lower today, marking four consecutive sessions of declines amid market speculation on potential interest rate hikes.

2026. g. 4. sept. 23:37 UTC

CRISPR Therapeutics AG shares rose in after-market trading, reflecting a modest increase since Friday's close, aligning with Beam Therapeutics' sector performance.

2026. g. 3. sept. 23:56 UTC

CRISPR Therapeutics AG shares are lower in after-hours trading, continuing a decline since Thursday's close, despite broader market gains. No specific news was identified.

2026. g. 2. sept. 19:46 UTC

CRISPR Therapeutics AG shares are lower today, continuing a four-day decline amid rising U.S. Treasury yields and inflationary pressures affecting the biotechnology sector.

2026. g. 1. sept. 23:06 UTC

CRISPR Therapeutics AG shares are lower in after-market trading, with no specific news identified to explain the movement. The stock has declined in three consecutive sessions.

2026. g. 31. aug. 23:06 UTC

CRISPR Therapeutics AG shares are higher in after-market trading, reflecting stable performance amid broader economic sentiment and expectations for a potential rate hike.

2026. g. 29. aug. 00:02 UTC

CRISPR Therapeutics AG shares are lower in after-market hours, continuing a trend of notable weakness amid rising market expectations for an interest rate hike.

2026. g. 28. aug. 22:51 UTC

CRISPR Therapeutics AG shares are lower in after-market hours, continuing a trend of weakness since Friday's close with no specific news identified.

2026. g. 27. aug. 23:02 UTC

CRISPR Therapeutics AG shares are higher in after-market trading, reflecting overall strength despite a slight pullback from earlier highs. No specific news was identified.

2026. g. 26. aug. 23:02 UTC

CRISPR Therapeutics AG shares are higher in after-market hours, maintaining strength above the 20-day moving average and near the upper end of their one-month range.

2026. g. 25. aug. 23:06 UTC

CRISPR Therapeutics AG shares are lower in after-market hours, reflecting a decline after Tuesday's close, despite a significant gain over the past month.

2026. g. 24. aug. 23:01 UTC

Shares of CRISPR Therapeutics AG declined in after-market trading, despite briefly recovering earlier in the session. The stock remains above its 20-day moving average.

2026. g. 21. aug. 23:36 UTC

CRISPR Therapeutics AG shares are higher in after-market trading, maintaining a position above the 20-day moving average and near the one-month range's upper end.

2026. g. 20. aug. 19:51 UTC

Shares lower today amid broader market pressures; SPDR S&P Biotech declines.

2026. g. 19. aug. 23:01 UTC

CRISPR Therapeutics AG shares are lower in after-market trading, continuing a decline since Wednesday's close amid notable volatility.

2026. g. 18. aug. 22:16 UTC

CRISPR Therapeutics AG shares are lower in after-market trading, reflecting unusual downward momentum amid broader market declines in major U.S. tech stocks.

2026. g. 17. aug. 23:06 UTC

CRISPR Therapeutics AG shares are lower in after-market trading, reflecting broader market sentiment affecting small-cap stocks amid a slight decline in the Russell 2000 Index.

2026. g. 14. aug. 19:16 UTC

CRISPR Therapeutics AG shares are lower today amid broader investor caution following a decline in U.S. retail sales for July.

2026. g. 13. aug. 23:46 UTC

CRISPR Therapeutics AG shares are higher in after-market trading, reflecting a positive trend in the biotechnology sector amid favorable economic conditions.

2026. g. 11. aug. 19:21 UTC

CRISPR Therapeutics AG shares are trading higher amid rising oil prices and inflation concerns ahead of upcoming U.S. inflation data. No specific news was identified.

2026. g. 10. aug. 23:06 UTC

No specific news was identified for CRISPR Therapeutics AG, which traded roughly flat during after-market hours, remaining near the upper end of its one-month range.

2026. g. 7. aug. 20:06 UTC

CRISPR Therapeutics AG is gaining amid positive social media sentiment and bullish chart patterns, aligning with the upward trend in the ARK Genomic Revolution ETF.